Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Contact us to schedule a telehealth appointment with one of our highly trained doctors today.
The STEP 1 trial studied semaglutide 2.4 mg weekly in adults without diabetes and found 14.9% mean body weight loss versus 2.4% with placebo at 68 weeks
Conversely, semaglutide, with strong cardiovascular outcomes and weight-loss efficacy, may be better suited for individuals with obesity, T2DM, or high cardiometabolic risk, where it can improve histology and provide extra-hepatic benefits through calorie reduction and glycemic control
For example, those with a higher starting weight often experience more significant initial weight loss
This great-tasting, ready-to-drink formula supports endurance and recovery by helping your cells metabolize fat into energy
US$ 26.68
.png)
US$ 29.07
US$ 26.97
US$ 21.35
US$ 22.65
US$ 24.89
